The company is cashing in on the liquidity in the stock markets and the appetite for equities.
The money may not be put to immediate use for the three greenfield projects that the company proposes to set up as the Rs 16,000 crore capital expenditure outlay will be spent over the next couple of years. However, with the stock market on a roll and foreign institutional investors buying heavily, valuations are rich and is probably a good time to cash in.
The company is reportedly issuing shares at a price of nearly Rs 131 a share, close to the current price of Rs 135. The stock has been doing well in recent weeks and a placement at this price wouldn’t result in too much of a dilution in the equity capital.
Even if the equity is diluted by 10 per cent, it wouldn’t matter too much, say analysts, because Hindalco, (without Novelis) plans to treble aluminium capacity in a few years and that would boost earnings. While demand in the Asian and South American markets is recovering, the outlook in the Europe and North America, which accounts for around two-thirds of the company’s consolidated sales, remains somewhat uncertain.
However, Hindalco’s subsidiary Novelis beat the Street’s expectations for the September 2009 quarter posting a second consecutive quarter of profits. The company reported sales of $2 billion, a sequential rise of 10 per cent, with aluminium shipments increasing 5 per cent quarter-on-quarter.
Most of the growth was driven by Asia and South America. The adjusted earnings before interest depreciation and tax (Ebitda) came in at $180 million, again showing a sequential increase. Analysts, however, point out that while the net earnings came in close to $ 200 million, they did include some unrealised gains on derivatives.
With Novelis on the mend and Hindalco’s stand-alone earnings seeming to have bottomed out, the company is certainly in better shape than it was six months ago. However, analysts aren’t too convinced on aluminium prices and moreover, they observe that the impending dilution will have some impact on the stock. As such, they believe the stock could be an underperformer from the current levels of Rs 135.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
